Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.
4d
News-Medical.Net on MSNStudy finds no benefit of early IABP use in cardiogenic shock patientsCompared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
4d
News-Medical.Net on MSNHeart failure patients benefit from dapagliflozin after TAVR procedurePatients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results